There’s an idea floating around that once Warren Buffett is no longer part of Berkshire Hathaway (BRK.A)(BRK.B), it will collapse. At a minimum, there’s concern that the “Buffett Premium” can be attributed to his individual skill:
More broadly, his value add is in capital allocation, which is basically the art of determining what to do with cash. He is objectively superior at that, which increases the likelihood of the company’s cash balances (and future cash income streams) being invested to earn a high return.
But Buffett’s made it clear that Todd Combs and Ted Weschler have previously done, and continue to do, a superior job. For example:
Both men are hedge fund veterans with impressive track records. For example, Weschler’s fund delivered 1,236% in gains in just 11 years before he closed it — roughly 9 times the gain of Buffett’s stock portfolio during the same time frame.
Combs ran a hedge fund from 2005 to 2010, and his returns over that period were 34% whereas the S&P pulled about 3%. So, again, these guys know what they are doing on the stock picking side of things.
Top 5 Warren Buffett Stocks To Watch Right Now: Westinghouse Air Brake Technologies Corporation(WAB)
- [By WWW.MONEYSHOW.COM]
Westinghouse Air Brake Technologies Corporation (WAB) scores highly based on my Warren Buffett-based model, which is based on the book Buffettology, and also the Peter Lynch-inspired approach that uses the method outlined by Lynch in One Up on Wall Street.
Top 5 Warren Buffett Stocks To Watch Right Now: Apogee Enterprises, Inc.(APOG)
- [By Dan Caplinger]
Apogee Enterprises (NASDAQ:APOG) has benefited greatly from the rebound in construction activity recently, which has helped the architectural glass and framing specialist bounce back from difficult conditions in past years. Yet despite solid business conditions throughout 2017, Apogee stock has struggled as investors seemed to question whether its growth path was sustainable.
- [By Garrett Baldwin]
The price of Bitcoin surged more than 17% to top $8,000 in a rapid move that surprised many investors this morning. The sudden rally appears to be the result of a short squeeze, according to CNBC contributor Brian Kelly. This means that investors who had been betting on a decline in the price of the world’s largest cryptocurrency had been forced to jump back and buy the currency again. A lot of people have been betting on a decline in the price of Bitcoin heading toward the April 17 tax deadline. The expectation is that many people will need to sell their Bitcoin in order to raise cash to meet tax obligations. Here’s our latest daily insight on why the Bitcoin bear market may end very soon.
Markets gains have been capped by concerns about the latest news out of the Federal Reserve. On Wednesday, minutes from the Fed’s most recent meeting indicated that policy makers are prepared to raise interest rates several more times in the coming months in order to stave off concerns about inflation.
Four Stocks to Watch Today: BLK, FB, DAL
Shares of BlackRock Inc. (NYSE: BLK) are on the move after the company reported earnings before the bell. The firm reported earnings per share (EPS) of $6.70. Analysts projected the firm would report EPS of $6.45 on top of $3.28 billion in revenue. The firm topped revenue expectations. The firm noted that an increase in its consulting fees and the recent tax reform bill helped bolster its profitability by 27%.
The stock of Facebook Inc. (Nasdaq: FB) has climbed more than 6% since Tuesday. Investors cheered the testimony of CEO Mark Zuckerberg, who appeared before Congress for two days to discuss his company’s privacy policies. The CEO and his firm have been under intense scrutiny since news broke that 87 million user accounts had been accessed without permission by consulting firm Cambridge Analytica during the 2016 election season. The firm had ties to President Trump’s campaign.
Delta Air Lines Inc. (NYSE: DAL) reported ea
- [By WWW.MONEYSHOW.COM]
Let me introduce you to Apogee Enterprises (APOG) a company with “yuge” profit potential. Founded in 1949 and headquartered in Minneapolis, Minnesota, APOG designs and develops glass solutions for commercial buildings.
Top 5 Warren Buffett Stocks To Watch Right Now: Partner Communications Company Ltd.(PTNR)
- [By Lisa Levin]
In trading on Monday, telecommunications services shares rose by just 0.2 percent. Meanwhile, top losers in the sector included B Communications Ltd (NASDAQ: BCOM), down 4 percent, and Partner Communications Company Ltd (ADR) (NASDAQ: PTNR), down 2 percent.
- [By Monica Gerson]
Partner Communications Company Ltd (ADR) (NASDAQ: PTNR) is expected to post earnings for the recent quarter.
Noah Holdings Limited (ADR) (NYSE: NOAH) is estimated to post financial results for its latest quarter.
- [By Lisa Levin]
In trading on Thursday, telecommunications services shares fell 0.12 percent. Meanwhile, top losers in the sector included China Mobile Ltd. (ADR) (NYSE: CHL), down 3 percent, and Partner Communications Company Ltd (ADR) (NASDAQ: PTNR), down 1.5 percent.
Top 5 Warren Buffett Stocks To Watch Right Now: Sempra Energy(SRE)
- [By David Dittman]
PG&E Corp (NYSE: PCG), Edison International (NYSE: EIX) and Sempra Energy (NYSE: SRE) are the parent entities of California’s investor-owned utilities.
- [By Lisa Levin]
Sempra Energy (NYSE: SRE) announced plans to acquire Oncor for $9.45 billion in cash.
Sempra Energy projects the deal to complete in the first half of 2018.
- [By WWW.THESTREET.COM]
The upgrade comes after Berkshire’s deal with Energy Future Holdings Corp to acquire its Oncor Electric Delivery interest was terminated Monday. Sempra Energy (SRE) agreed to buy Oncor for $9.45 billion, besting Berkshire’s $9 billion offer.
- [By Lisa Levin]
In trading on Friday, utilities shares fell by 0.93 percent. Meanwhile, top losers in the sector included Sempra Energy (NYSE: SRE), down 3 percent, and CenterPoint Energy, Inc. (NYSE: CNP), down 3 percent.
- [By Shanthi Rexaline]
Giving six reasons for Sempra Energy (NYSE: SRE)’s above-peer-average growth, Argus said it is reiterating its Hold rating on the shares of the company, while it is also maintaining its long-term Buy rating.
Top 5 Warren Buffett Stocks To Watch Right Now: Ultragenyx Pharmaceutical Inc.(RARE)
- [By Johanna Bennett]
Nothing guts a drug stock like bad clinical trial data. Shares of Ultragenyx Pharmaceutical (RARE) fell as much as 10% after a seizure medication failed in a phase II study.
Trading at a recent $72.22, the shares were down 7.7% after earlier falling as much as 10% to $70.51
The seizure drug UX007 was tested as a treatment for glucose transporter type-1 deficiency syndromeor Glut1 DSamong a small group of patients. Data released Wednesday showed that it only cut the rate of seizures in the drug arm by 13.4% compared to the placebo arm, falling short of statistical significance.
Investigators, though, teased out a clinically — though not statistically — significant benefit for patients experiencing what are called absence seizures. Ultragenyx now intends to focus on that in a Phase III pivotal trial.
Leerik analyst Joseph Schwartz called the selloff a buying opportunity.
We had been cautious on this asset (and its two programs – G1DS and long-chain fatty acid oxidation disorder/LC-FAOD; LINK) – but believe the selling pressure after mkt. presents a buying opportunity ahead of a more de-risked X-linked hypophosphatemia (XLH) Ph.3 data in 1H17.
Cowen analyst Eric Schmidt remained convinced of RAREs long-term prospects thanks to a diversified orphan disease pipeline. And analysts at Credit Suisse see more catalysts ahead in 2017.
We are buyers on a pullback and we like RAREs setup for the remainder of 2017…Remaining 2017 catalysts keep us buyers on a pullback: We see Q2:17 KRN23 ph3 adult XLH data, H1:17 rhGUS FDA/EMA submission, potential KRN23 CHMP decision in mid-17 (based on late-2016 EMA submission/validation), H2:17 Ace-ER ph3 GNEM data, and potential KRN23 FDA submission in late-17/early-18 as upcoming catalysts worth owning for.
- [By Jon C. Ogg]
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was indicated down 7% at $72.85 on Thursday due to results from a seizure medication study. It was downgraded to Neutral from Overweight at Piper Jaffray, and Wedbushlowered its target for the stock.
- [By Chris Lange]
Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.
- [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston